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to oxidative stress, glial cell differentiation, DNA repair, and PPAR signalling, and 
DOVRVLJQL¿FDQWO\HQULFKHGZLWKFHOOXODUVHQHVFHQFHJHQHV3 î-03). In 
DGGLWLRQDKLJKQXPEHURIVLJQL¿FDQWO\GRZQUHJXODWHGJHQHVLQ6(31DUHORFDOL]HG
WRFKURPRVRPHJHQHVIURPFKU±)'5 î
10-23DQGJHQHVIURPFKU±)'5 î) including 
BRD1, EP300, HDAC10, HIRA, HIC2, MKL1, and NF2. Evaluation of NF2 co-expressed 
JHQHVIXUWKHUFRQ¿UPVWKHHQULFKPHQWRIFKURPRVRPHUHJLRQV)LQDOO\V\VWHPDWLF




Ependymomas are primary tumors of the central 
QHUYRXVV\VWHP&16UHSUHVHQWLQJíRIDOO&16
WXPRU>@+LVWRORJLFDOO\WKH\KDYHEHHQFODVVL¿HGLQWR
three grades according to the World Health Organization 
(WHO): grade I (subependymomas and myxopapillary 
ependymomas), grade II (classic ependymomas), and 
grade III (anaplastic ependymomas) [2]. These tumors 
originate from either intracranial or spinal regions of 
the CNS. Spinal ependymoma (SEPN) constitutes 
approximately 34.5% of ependymomas and accounts for 
VSLQDOFRUGJOLRPDVPDNLQJWKHPWKHPRVWFRPPRQ
JOLDO WXPRUVRI WKHDGXOW VSLQH >@:KLOHRIDOO
childhood ependymomas are intracranial, SEPN are more 
FRPPRQO\IRXQGLQDGXOWVRIWR\HDUVRIDJH>@
where standard treatment of SEPN is aiming for complete 
resection. Although, SEPN generally have better prognosis 
than intracranial tumors, recurrence rate can be as high 
DV í ZLWKRXW DGMXYDQW WKHUDS\ KRZHYHU WKH
EHQH¿FLDOUROHRIDGMXYDQWFKHPRWKHUDS\RUUDGLRWKHUDS\
LQ6(31 LV FRQWURYHUVLDO >@0RVW FXUUHQWO\NQRZQ
prognostic factors for SEPN are based on clinical and 
histological criteria, such as extent of tumor resection, and 
histological grade. The results of existing studies on these 
SURJQRVWLFPDUNHUVDUHFRQWUDGLFWRU\7KHUHIRUHWKHUHLVD
need to improve the understanding of the biology of SEPN 
in order to develop more accurate prognostic signatures 
and identify new therapeutic targets.
Few studies have examined the genetics of SEPN 
compared to intracranial ependymomas. Ebert et al 
found loss of heterozygosity (LOH) on chromosome 22q 
LQJUDGH,,FDVHVDQGJUDGH,,,FDVH6(31
1) PXWDWLRQV LQ JUDGH ,, 6(31  FDVHV DQG
found no mutations in intracranial and myxopapillary 
ependymomas [8]. In a study with 52 tumors from 
45 patients, Lamsuzs et al detected LOH on chr22q 





of the NF2 gene product, merlin in 5 out of 27 cases, all of 
ZKLFKZHUHIURPVSLQDO>@
Microarray-based expression studies have also 
been used to compare SEPN with intracranial tumors and 
correlate molecular signatures with clinical and histologic 
characteristics. A study by Korshunov et al examined 39 
ependymal neoplasms including ten SEPN and detected 14 
genes that were more highly expressed in SEPN compared 
to intracranial ependymomas including HOXB5, PLA2G5 
and ITIH2 >@ /XNDVKRYDY =DQJHQ et al reported 
¿YHJHQHVTFAM, EDN1, GAS2L1, HUMRTVLH3 and 
ADAM9) that were preferentially expressed in SEPN 
by comparing grade II adult SEPN (n = 8) and adult 
intracranial ependymomas (n = 4) from a cohort of 47 
ependymoma patients [12]. By comparing tumor samples 
IURP6(31DQGLQWUDFUDQLDOHSHQG\PRPDV3DOPet 
al reported the over-expression of HOX genes in SEPN 
and up-regulation of several genes of Notch, Hedgehog, 
and BMP signaling pathways in intracranial ependymoma 
[13]. Finally, Taylor et al compared gene expression 
microarrays of tumor samples from SEPN (n = 3), 
supratentorial (n = 5), and posterior fossa (n = 21), and 
LGHQWL¿HGWKHH[SUHVVLRQVLJQDWXUHIRU6(31WKDWFRQVLVWHG
of 184 genes including HOX genes HOXA7, A9, HOXB6, 
B7, HOXC8, C10, and IGF1 [14]. 
The aforementioned gene expression studies are 
limited to a small number of samples and are usually 
DQDO\VHGLQLVRODWLRQ0HWDDQDO\VLVDSSURDFKHVPDNHLW
possible to combine multiple independent gene expression 
datasets and increase the statistical power for gene 
discovery. Such meta-analysis approaches have been 
successfully used to identify transcriptional signatures in 
FDQFHU >@DQGDJLQJ>@ ,QGLYLGXDOJHQHH[SUHVVLRQ
studies are limited by systematic biases at both biological 
and technical levels, which hinder the broader application 
RI WKHLU ¿QGLQJV 0HWDDQDO\VLV FDQ FRQWURO IRU VXFK
confounding factors by increasing the statistical power 
to detect consistent changes across multiple datasets. 
No systematic multi-cohort analysis has yet evaluated 
transcriptional alterations between SEPN and intracranial 
ependymomas. The present study uses microarray datasets 
from three independent cohorts to compare the biology 
of SEPN and intracranial ependymomas to identify 
unique molecular characteristics of SEPN such as altered 
expression of cellular senescence and chromosome 22 
genes.
RESULTS
We applied two different meta-analysis approaches 




ependymomas by both methods (Supplementary Table 1).
7DEOH  (QULFKPHQW RI .(** SDWKZD\V DPRQJ VLJQL¿FDQWO\ XSUHJXODWHG
JHQHVLQVSLQDOHSHQG\PRPDV 
Pathway N FDR
Protein processing in endoplasmic reticulum 28 î
7LJKWMXQFWLRQ 21 î
Nucleotide excision repair  î
Cell adhesion molecules (CAMs) 19 î
Pyrimidine metabolism 15 î
Pyruvate metabolism 9 î
RNA transport 19 î
Purine metabolism  î
PPAR signaling pathway 11 î
Proteasome 8 î
$GKHUHQVMXQFWLRQ 11 î
Oxidative phosphorylation  î
Focal adhesion 21 î
Enrichment P values for KEGG pathways were calculated using the Hyper-geometric WHVWDQGFRUUHFWHGIRUPXOWLSOHWHVWLQJXVLQJ%HQMDPLQL	+RDFKEHUJPHWKRG7KHSDWKZD\VZLWKDGMXVWHG3YDOXHVZHUHVHOHFWHG1QXPEHURIJHQHVLQWKHSDWKZD\)'5IDOVHGLVFRYHU\UDWH
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([SUHVVLRQDQDO\VLVKLJKOLJKWVGLYHUVHSURFHVVHV
DQG SDWKZD\V DPRQJ RYHUH[SUHVVHG JHQHV LQ
SEPN
Of the 3,182 differentially expressed genes between 
6(31DQGLQWUDFUDQLDOHSHQG\PRPDVZHUH
consistently up-regulated in SEPN (Figure 1A). The 
PRVWVLJQL¿FDQWO\XSUHJXODWHGJHQHV LQFOXGHGHOXB7 
(pooled effect size on log2, ES = 2.74, FDR = 1.41 × 
-31), CTFR (6 )'5 î-22), HOXB5 
(6 )'5 î-19), and CTTNBP2 (ES = 
)'5 î). Other interesting genes that 
have increased expression in SEPN included EZH1, IDH3, 
NEFL, and NELL2. Of the 27 HOX genes annotated in 
WKHPLFURDUUD\VZHUHVLJQL¿FDQWO\XSUHJXODWHGLQWKH
SEPN (Figure 1B). Gene ontology (GO) analysis of over-
H[SUHVVHGJHQHVVKRZHGVLJQL¿FDQWRYHUUHSUHVHQWDWLRQRI
JHQHVLQYROYHGLQDQWHULRUSRVWHULRUSDWWHUQVSHFL¿FDWLRQ
 JHQHV )'5    î ), apoptotic process (72 
JHQHV)'5 îFHOOF\FOHJHQHV)'5 
îFLOLXPDVVHPEO\JHQHV)'5 î-
DQGFHOOSUROLIHUDWLRQJHQHV)'5 î), as 
well as genes involved protein folding, DNA replication, 
mitochondrial electron transport, NADH to ubiquinone, 
response to oxidative stress, and cell redox homeostasis 
(Supplemental Table 2). In addition, genes involved in 
DNA repair processes such as nucleotide-excision repair 
DQG GRXEOHVWUDQG EUHDN JHQHV LQ VLJQDOLQJ SDWKZD\V
VXFK DV SRVLWLYH UHJXODWLRQ RI ,NDSSD% NLQDVH1)
NDSSD%FDVFDGHSRVLWLYHUHJXODWLRQRI0$3.FDVFDGH
DQGJOLDOFHOOGLIIHUHQWLDWLRQZHUHVLJQL¿FDQWO\HQULFKHG
in SEPN (Supplemental Table 2). Our pathway analysis 
LGHQWL¿HG3URWHLQSURFHVVLQJLQHQGRSODVPLFUHWLFXOXPDV
the top canonical pathway followed by pathways involved 
in DNA repair, cell adhesion, metabolism, and PPAR 
signaling (Table 1). 
7DEOH7RSJHQHVWKDWDUHKLJKO\FRUUHODWHGZLWK1)JHQHH[SUHVVLRQ 
Gene Location ES SE FDR
MIEF1 22q13   î-19
NDUFA6 22q13.2   î
ASCC2 22q12.1   î
ADSL 22q13.2   î
PITPNB 22q12.1   î-14
RPS19BP1 22q13.1   î-12
UFD1L 22q11.21   î
MTMR3 22q12.2   î
TCF20 22q13.3   î-18
DRG1 22q12.2   î
DGCR2 22q11.21   î-11
EIF3D 22q13.1   î
SAMM50 22q13.31   î
SRRD 22q12.1   î
ITPK1 14q31   î-18
EIF4ENIF1 22q11.2   î
MTHFD1 14q24   î
TTC38 22q13   î-17
UBE2L3 22q11.21   î
THOC5 22q12.2   î
TTLL12 22q13.31   î-17
EIF3L 22q   î
ATXN10 22q13.31   î
FCHSD2 11q13.4   î
NOL12 22q13.1   î
3HDUVRQ FRUUHODWLRQ FRHI¿FLHQWV U EHWZHHQ HDFK JHQH H[SUHVVLRQ DQG
NF2 expression were calculated in each data set and combined using the 
DerSimonian-Laird random-effect meta-analytical approach by calculating =PHDQRIU(6DQGLWVVWDQGDUGHUURU6(/RFDWLRQ&KURPRVRPHORFDWLRQ
(6(IIHFWVL]H6(VWDQGDUGHUURU)'5IDOVHGLVFRYHU\UDWH
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Cancer incidence and mortality increases with age 
DQGWKXVDJHLVFRQVLGHUHGDVDSULPHULVNIDFWRUIRUVHYHUDO
types of cancers, including gliomas [17, 18]. In addition, 
emerging evidences indicate that aging and cancer are 
closely related and mechanisms underlying the cellular 
VHQHVFHQFH&6SURJUDPPD\OLQNWKHVHWZRSURFHVVHV
[19]. To determine whether similar processes are shared 
between SEPN and CS, we compared the genes associated 
with CS with up-regulated genes in SEPN. We obtained 
D VHW RI  FDQGLGDWH JHQHV WKDW DUH LQYROYHG LQ &6
IURPWKHSXEOLVKHGVWXG\>@7KH&6OLVWLVDPDQXDOO\
curated set of candidate genes implicated by genetic or 
51$LQWHUIHUHQFH51$LLQWHUYHQWLRQVJHQHNQRFNRXW
partial or full loss-of-function mutations, RNAi-induced 
gene silencing, overexpression), which reportedly cause 
cells to induce, inhibit or reverse CS, and genes shown 
WREHPDUNHUVRI&6$PRQJWKHXSUHJXODWHGJHQHVLQ
63(1 WKHUH ZDV D VLJQL¿FDQW HQULFKPHQW IRU WKH &6
DVVRFLDWHGJHQHVK\SHUJHRPHWULFWHVWJHQHV3 î
), which includes oncogenes (BCL2, CDK6, MDM2, 
and NR4A3F\WRNLQHVDQGJURZWKIDFWRUVAGT, CYR61, 
FGF1, and IGF1), transcription factors (MECP2, PCGF2, 
PER2, and TP63), member of RAS superfamily of small 
GTP-binding proteins (RAC1), and genes involved in 
the oxidative stress pathway (SOD1) (Figure 2 and 
Supplementary Table 3). 
&KURPRVRPH  JHQHV DUH XQGHUH[SUHVVHG LQ
SEPN
One of the most frequent genomic alterations 
detected in sporadic ependymomas was the loss of 
FKURPRVRPHZLWKWKHIUHTXHQF\UDQJLQJIURP
to 71% [8, 9]. In addition, loss of heterozygosity (LOH) 
on chromosome 22q has been found more frequently 
in intramedullary SEPN and more often in adults than 
the pediatric ones [21, 22]. To investigate whether 
chromosome loss alter expression of endogenous genes, 
ZH LGHQWL¿HG GLIIHUHQWLDOO\ H[SUHVVHG JHQHV WKDW DUH
VLJQL¿FDQWO\ GRZQ UHJXODWHG LQ 6(31  JHQHV DW
)'56XSSOHPHQWDU\7DEOHDQGWHVWHGIRUWKH
enrichment of chromosomal regions. The positional gene 
enrichment analysis revealed that many down-regulated 
JHQHVLQ6(31ORFDOL]HGWRVSHFL¿FFKURPRVRPDOUHJLRQV
rather than genes randomly distributed in the genome. 
Most prominently, a high number of genes were localized 
to a 92.4 Mbp region (81 genes from chr22: 43325255  
)'5 î-23) and a 32.5 Mbp region 
JHQHVIURPFKU±)'5 
î ) of the chromosome 22 (Supplementary Table 
 7R FRQ¿UP WKHVH REVHUYDWLRQV ZH DOVR SHUIRUPHG
enrichment analysis of cytogenetic bands with the 
GSEA method. We observed that 51 genes located in 
FKUTK\SHUJHRPHWULFWHVW)'5 î-27), 27 
JHQHV LQFKUT)'5 î-13DQGJHQHV
LQFKUT)'5 î-11) were highly enriched 
DPRQJ JHQHV WKDW ZHUH VLJQL¿FDQWO\ GRZQUHJXODWHG
in SEPN (Supplementary Table 4). Furthermore, genes 
ORFDWHGLQF\WRJHQHWLFEDQGVFKUSJHQHV)'5 
î-13FKUTJHQHV)'5 î), 
DQGFKUTJHQHV)'5 î) were also 
enriched among down-regulated genes (Supplementary 
7DEOH6WULNLQJO\RIJHQHVORFDWHGRQFKURPRVRPH
22 (271 out of 321 chr22 genes that were detected in the 
meta-analysis) were under expressed and 125 of them were 
VLJQL¿FDQWO\GRZQUHJXODWHGLQVSLQDOZKHQFRPSDUHGWR
intracranial ependymomas (Figure 3A). These included 
several cancer-associated genes such as MKL1, EP300, 
NF2, and HIC2 and chromatin binding genes BRD1, 
HIRA, and HDAC10 (Figure 3B). 
1)DVVRFLDWHGJHQHVLQHSHQG\PRPDDUHORFDWHG
on chromosome 22 
Our analysis of differential expression in relation 
WR FKURPRVRPH  LGHQWL¿HG D WXPRU VXSSUHVVRU JHQH
QHXUR¿EURPLQNF2), which is located at chromosome 
22q12.2 and showed decreased expression in SEPN (ES 
 )'5 î). Higher incidence of spinal 
HSHQG\PRPDVLQSDWLHQWVZLWKQHXUR¿EURPDWRVLVW\SH
and frequent of loss of the NF2 gene in SEPN have been 
reported in numerous studies [23, 24]. This led us to 
further investigate the effect of NF2 on the expression of 
other SEPN genes. We used three independent microarray 
datasets to identify potential co-expressed genes of NF2 
in an un-biased manner. The meta-analysis of correlations 
between NF2 gene expression and other genes resulted 
LQJHQHV=PHDQRIFRUUHODWLRQVU!DQG)'5
  6XSSOHPHQWDU\ 7DEOH  7KH PRVW KLJKO\
correlated gene with NF2-expression, the gene encoding 




in the NF2 co-expressed genes residing at 22q13, 22q12, 
22q11, 22q, 14q23, 14q24, and 1q25 (Supplementary 
7DEOH)URPDWRWDORINF2 co-expressed genes, 
 ZHUH VLJQL¿FDQWO\GRZQUHJXODWHG LQ6(31
6XSSOHPHQWDU\7DEOH  2XW RI ¿IWHHQ JHQHV WKDW DUH
physically located close to NF2ÀDQNLQJUHJLRQRI
Kb), fourteen were down-regulated in SEPN and nine 
RI WKHP ZHUH VLJQL¿FDQWO\ FRUUHODWHG ZLWK NF2 gene 
expression (Supplementary Table 5). 
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7DEOH3ULRULWL]DWLRQRI&KURPRVRPHJHQHVE\QHWZRUNDQGNF2JHQHFRH[SUHVVLRQDQDO\VHV
Correlation with NF2 gene 
expression
Symbol Gene name Location
DAPPLE3YDOXH ES SE FDR
EP300 ($ELQGLQJSURWHLQS 22q13.2    
HIRA Histone cell cycle regulator 22q11.21    
MN1
Meningioma (disrupted in balanced 
translocation) 1
22q12.1    
SGSM3 Small G protein signaling modulator 3 22q13.1-q13.2    î-14
SUSD2 Sushi domain containing 2 22q11-q12    
SREBF2
Sterol regulatory element binding 
transcription factor 2
22q13    î-13
RASD2 RASD family, member 2 22q13.1    î
LZTR1 /HXFLQH]LSSHUOLNHWUDQVFULSWLRQUHJXODWRU 22q11.21    î
)LJXUH,QFUHDVHGH[SUHVVLRQRIFHOOXODUVHQHVFHQFHJHQHVLQ6(31Box plots showing log
2
 expression levels (y-axis) of six 
cellular senescence genes (BCL2, MDM2, RAC1, TP63, IGF1, and SOD1) from spinal (SP) and intracranial ependymomas. Expression 
values from three different studies: CBTRC, Toronto, and Heidelberg are displayed for each gene.
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Prioritisation of Chromosome 22 genes by 
LQWHJUDWLRQ RI WKH LQWHUDFWRPH ZLWK 1)
DVVRFLDWHGJHQHV
We next reasoned that altered expression of 
chromosome 22 genes could help to identify potential 
candidate genes of ependymoma in addition to a NF2 
gene. To systematically evaluate and prioritize genes 
located on chromosome 22 that are associated with SEPN, 
we used the integration of protein-protein interaction (PPI) 
GDWDZLWKJHQHH[SUHVVLRQGDWD:H¿UVWFRQVWUXFWHGWKH
33, QHWZRUN XVLQJ VLJQL¿FDQWO\ GRZQ UHJXODWHG JHQHV
in SEPN that are located on chromosome 22 as seed 
genes excluding NF2. We found there were 11 of 125 
FKURPRVRPHJHQHVSDUWLFLSDWLQJLQWKHGLUHFWQHWZRUN
(Supplementary Figure 1). The changes in connectivity 
LQ WKH LQIHUUHG QHWZRUN ZHUH FDOFXODWHG E\ FRPSDULQJ
UDQGRP QHWZRUNV RI HTXDO VL]H DQG VHHG JHQHV ZHUH
UDQNHGE\3YDOXHRILQFUHDVHGFRQQHFWLYLW\7KLVDQDO\VLV
LGHQWL¿HGHLJKWJHQHV WKDWZHUH UDQNHGE\ WKHQHWZRUN
DOJRULWKPZLWKD3YDOXH7DEOH7KHVHHLJKW
candidate genes represent the most highly connected, and 
therefore, potentially most functionally important ones. 





of NF2 (Table 3). 
DISCUSSION
Understanding distinct molecular characteristics 
exhibited by ependymomas according to their tumor 
location in the brain is becoming more important. 
Systematic analysis of molecular data from ependymomas 
have long been sought, however, there currently exists few 
studies that compared ependymomas arising in the spine 
to those intracranial. Here we demonstrate through meta-
analysis approaches by combining multiple independent 
GDWD VHWV WKDW JHQH H[SUHVVLRQ SUR¿OHV RI WXPRUV IURP




SEPN. Most, but not all, biological processes involved in 
WKHKDOOPDUNVRIFDQFHUDUHHQULFKHGZLWKRYHUH[SUHVVHG
genes in SEPN. Genes related to cellular senescence 
DUHDOVRKLJKO\HQULFKHG LQ6(31 ,QDGGLWLRQZH¿QG
WKDW WKH PDMRULW\ RI WKH JHQHV IURP FKURPRVRPHV 
relatively decreased expression levels in tumors from 
the spine. Overall, we provide a systematic analysis of 
FRPSUHKHQVLYHJHQHH[SUHVVLRQGDWDIRUDVVHVVLQJVSHFL¿F
biological processes of SEPN.
Our results showed that SEPN are characterized 
E\GLYHUVHDVHWRINQRZQDQGQRYHOELRORJLFDOSURFHVVHV
DQG SDWKZD\V 3UHYLRXV ZRUN WKDW XVHG VPDOOHU VWXG\
samples reported up-regulation of HOX genes in SEPN 
when compared with ependymomas from intracranial 
UHJLRQV>@ ,Q WKHFXUUHQWVWXG\ZHLGHQWL¿HGWKH
up-regulation of multiple homeobox family members that 
include ANTP class homeoboxes (HOX) not previously 
implicated in SEPN (HOXA: A2, A3, A5, and A10HOXB: 
B2, B3, B5, and B8HOXC: C8 and C13HOXD: D8, D9, 
and D10, see Figure 1). The HOX genes, encode a family 
of evolutionarily conserved transcription factors that have 
fundamental roles in specifying anterior-posterior body 
patterning and development of the spine [25]. As they 
are involved in cellular fate determination and stem cell 
renewal, several studies investigated their role in other 
WXPRUW\SHV>@3DUWLFXODUO\+2;JHQHVJURXS
play important roles in the normal development of the 
OXPERVDFUDO UHJLRQ >@ ,QGHHG WKH PRVW VLJQL¿FDQW
GO biological process detected in this study was the 
DQWHULRUSRVWHULRU SDWWHUQ VSHFL¿FDWLRQ 7KH FRPELQHG
analysis of large samples in our study from heterogeneous 
ependymoma patients recruited from different clinical 
VHWWLQJV SURYLGHV FRQ¿UPDWRU\ HYLGHQFH RI WKH
association of HOX genes in SEPN. Another important 
observation is the enrichment of genes involved in glial 
cell differentiation (DNER, ERBB2, IGF1, METRN, and 
NFIB) in SEPN. This observation is consistent with the 
HPHUJLQJHYLGHQFHWKDWUDGLDOJOLDOFHOOVDUHOLNHO\FHOOV
of origin for ependymomas [14]. The up-regulation of 
these glial cell differentiation genes and homeobox family 
of transcription factors may transform radial-glial cells 
into cancer stem cells in the development of SEPN. Our 
analysis also revealed novel biological processes such as 
antigen processing and presentation of antigen peptides 
YLD0+&FODVV,SRVLWLYHUHJXODWLRQRIWKH,ț%NLQDVH
1)ț%FDVFDGHSRVLWLYHUHJXODWLRQRIWKH0$3.FDVFDGH
and proteolysis that have genes with relatively increased 
expression in SEPN (Supplementary Table 1). These 
UHVXOWVSURYLGHGDWDGULYHQK\SRWKHVHVIRUIXWXUHZRUN
although we expect that further experimental evaluation 
will be necessary to understand the potential role of these 
biological processes in SEPN.
Among the up-regulated genes in SEPN were 
those that regulate DNA repair, DNA damage response, 
signal transduction by p53, response to oxidative 
stress, cell cycle, cell division, cell redox homeostasis, 
and mitochondrial electron transport (NADH to 
ubiquinone) (Supplementary Table 1). These genetic 
systems collectively play important roles in aging [27]. 
Several lines of evidence indicate that CS is a common 
SURFHVVWKDWOLQNVFDQFHUDQGDJLQJ>@6HQHVFHQWFHOOV
accumulate in ageing tissues, which may be due to an 
Oncotarget8www.impactjournals.com/oncotarget
)LJXUH'RZQUHJXODWHGJHQHVRI6(31FRQWULEXWHGWRWKHHQULFKPHQWRIFKURPRVRPHA. Expression levels (log
2
) of 





smoothed expression values (purple line) are shown. B. Box plots showing log
2
H[SUHVVLRQOHYHOV\D[LVRINH\JHQHVWKDWDUHORFDWHGRQ
chromosome (EP300, HIRA, and NF2) from spinal (SP) and intracranial ependymomas. Expression values from three different studies: 
CBTRC, Toronto, and Heidelberg are displayed for each gene.
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LQFUHDVHGVHQHVFHQFHUDWHDQGRUGHFUHDVHLQWKHUDWHRI
clearance of senescent cells. The onset of CS in tumor 
cells can typically be activated by aberrant activation of 
oncogenes or loss-of-function of tumor suppressor genes, 
and also by several stressors, including DNA damage, 
oxidative stress, and signaling through either MAPK or 
IGF [19]. To determine a degree of CS convergence with 
SEPN, we compared the CS-associated genes with genes 
that are up-regulated in SEPN. Our analysis uncovered 
HYLGHQFHVRIVLJQL¿FDQWRYHUODSEHWZHHQ&6DQG6(31
at a molecular level, identifying core biological processes 
and genes they share. For example, oncogenes: CDK6 
and MDM2, tumor suppressor gene: CHEK2, oxidative 
stress genes: SOD1 (encoding a member of the p53 family 
of transcription factors) and TP63, and IGF signaling 
genes: IGF1, IGFBP5 and IGFBP7. Since the incidence 
of ependymomas from the spine increases with age, it 
LV OLNHO\ WKDW WKHVHQHVFHQFHSDWKZD\ LV LQYROYHG LQ LWV
GHYHORSPHQW7RJHWKHUWKHVH¿QGLQJVDGGWRWKHJURZLQJ
ERG\RIHYLGHQFHWKDW&6OLQNVFDQFHUDQGDJHLQJDQGWKDW
biological process in SEPN have a considerable degree of 
convergence with CS.
Loss of chromosome 22 and LOH have been 
frequently found in sporadic SEPN, and alteration of 
FKURPRVRPHTLVREVHUYHGLQRI6(31>@
$QDO\VLVRIJHQHH[SUHVVLRQSUR¿OHVLQWKHFXUUHQWVWXG\
revealed the presence of many genes on chromosome 
22 that were down-regulated in SEPN, indicating the 
functional consequences of chromosome 22 loss. The 
observed 92.4 and 32.5 Mb large domains of repressed 
transcription of chromosome 22 that include hotspots 
regions 22q11, 22q12, and 22q13 is a result of a gene 
dosage effect due to unbalanced chromosomal alterations 
in SEPN. Potential tumor suppressor genes located within 
22q12 include NF2 ZKLFK H[KLELWV PDUNHGO\ UHGXFHG
mRNA expression in SEPN. The NF2 gene encodes the 
FERM domain protein Merlin, which is co-ordinately 
regulated by intercellular adhesion and attachment to 
the extracellular matrix [28]. Increased incidence of 
CNS tumors including schwannoma, meningioma, and 
HSHQG\PRPD KDV EHHQ UHSRUWHG LQ 1HXUR¿EURPDWRVLV
type 2 patients who carry a single mutated NF2 allele 
[23, 24]. The reduced expression of the tumor suppressor 
gene NF2LQ6(31UDLVHVWKHTXHVWLRQRIWKHVLJQL¿FDQFH
of expression alterations in other genes. From our meta-
analysis of correlations with NF2 gene expression, it 
LV OLNHO\ WKDW VLPLODU H[SUHVVLRQ DOWHUDWLRQV PD\ RFFXU
in genes located in close physical proximity to NF2. 
Interestingly, genes located on 22q13, 22q12, 22q11 are 
VLJQL¿FDQWO\ HQULFKHG DPRQJ NF2 co-expressed genes. 
7DNHQWRJHWKHUWKHVHUHVXOWVIXUWKHUHPSKDVL]HWKHORVVRI
chromosome 22 in the transcriptional regulation of SEPN, 
DQG FRQ¿UP WKH DOUHDG\ UHSRUWHG LPSRUWDQFH RI NF2 
transcriptional down-regulation.
The observed gene expression alterations over large 
regions of chromosome 22 suggest that these regions may 
harbour potential candidate genes commonly affected 
LQHSHQG\PRPDV7RSULRULWL]HVLJQL¿FDQWO\GRZQ
regulated chromosome 22 genes in SEPN, we used the 
SURWHLQSURWHLQLQWHUDFWLRQV33,QHWZRUNDQDO\VLVZLWK
the assumption that proteins associated with disease tend 
WR GLUHFWO\ LQWHUDFW ZLWK HDFK RWKHU :H WKXV LGHQWL¿HG
19 directly interacting proteins and investigated whether 
these PPI could help identify candidate genes within any 
RIWKHFKURPRVRPHJHQHVLGHQWL¿HGLQWKHFXUUHQW
VWXG\2XUDQDO\VLVLGHQWL¿HGHLJKWJHQHVEP300, HIRA, 
MN1, SGSM3, SUSD2, SREBF2, RASD2, and LZTR1, 
and all of them except MN1DUHVLJQL¿FDQWO\FRUUHODWHG
with NF2 gene expression. These convergent lines of 
evidence strongly suggest that the prioritized genes may 
have pivotal role in ependymomas susceptibility. The 
tumor suppressor gene, EP300UDQNHGKLJKHVWDPRQJDOO
eight genes, encodes histone acetyltransferase, p300 that 
have widespread genomic effects on chromatin structure 
and gene expression as well as non-genomic effects on 
protein function [29]. It participates in the regulation of a 
wide range of biological processes such as proliferation, 
cell cycle regulation, apoptosis, differentiation, and DNA 
GDPDJH UHVSRQVH > @7KH p300 protein functions 
primarily as a transcription cofactor for a number of 
QXFOHDU SURWHLQV LQFOXGLQJ NQRZQ RQFRSURWHLQV DQG
WXPRUVXSSUHVVRUSURWHLQV>@$QLQFUHDVLQJERG\
of evidence indicates that p300 may be important in 
cancer [31, 32]. Interestingly, p300 directly interacts 
with a transcription factor 1)ț%DVZHOODVZLWKWKHS
protein that encoded by a gene RELA. The detection of 
frequent C11orf95-RELA gene fusion in supratentorial 
ependymomas further supports the potential role of EP300 
in ependymomas. Further functional investigation of 
EP300 and other genes will provide pivotal information 
on the pathophysiology of ependymomas and potential 
therapeutic targets. 
In summary, this study provides a comprehensive 
and global view of genes altered in SEPN. Importantly, 
HQULFKPHQW RI DQWHULRUSRVWHULRU SDWWHUQ VSHFL¿FDWLRQ
response to oxidative stress, and cellular senescence 
genes distinguish the SEPN from intracranial 
ependymomas. We prioritized all chromosome 22 genes 
altered in ependymoma by comprehensive integration 
of distinct lines of evidence from different sources. 
7KHLGHQWL¿FDWLRQRI WKHVHFDQGLGDWHJHQHVSURYLGHVDQ






Three independent microarray datasets comprising 
D WRWDO RI  H[SUHVVLRQ SUR¿OHV IURP WXPRUV RI
ependymoma patients were used in this study. The 
VXSSOHPHQWDU\WDEOHUHSRUWVWKHVDPSOHVL]HPHDQDJH
DJHUDQJHJHQGHUDQGWKH*6(LGHQWL¿HURIWKHGDWDVHWLQ
the Gene Expression Omnibus (GEO) database. Dataset 1 
(CBTRC) contains tumor samples from intracranial (n = 
71) and spinal (n = 12) regions of ependymoma patients 
ZLWKPHDQDJHRIDQG\HDUV>@7KH&%75&
data were generated using the Affymetrix Human Genome 
83OXVDUUD\V'DWDVHW7RURQWRFRQVLVWVRI
intracranial tumors from patients with a mean age of 8.1 
and 19 spinal tumors from patients with a mean of age of 
\HDUV>@7KH7RURQWRGDWDZHUHJHQHUDWHGXVLQJ
WKH $II\PHWUL[ KXPDQ ([RQ  67 DUUD\V 'DWDVHW 
(Heidelberg) consists of tumor samples from intracranial 
Q DQGVSLQDOFRUGQ RISDWLHQWVZLWKPHDQ
age of 18.7 and 35.3 years [34]. The Heidelberg data were 
generated using the Agilent microarrays.
0LFURDUUD\GDWDDQDO\VLV
3UHSURFHVVLQJDQGQRUPDOL]DWLRQ
Expression intensity values were calculated at 
SUREHVHWOHYHOIRUWKH$II\PHWUL[83OXV&(/
¿OHVXVLQJWKHUREXVWPXOWLDUUD\DYHUDJH50$PHWKRG
>@ 3UREHVHWV WKDW DUH µDEVHQW¶ SUHVHQW  DEVHQW FDOO
XVLQJ0$6 LQDOO VDPSOHVZHUH¿OWHUHGRXW IURP WKH
analysis. Expression values were mapped from probeset 
to unique gene and the probeset with the highest mean 
expression value was selected when multiple probesets 
ZHUHPDSSHG WR WKHVDPHJHQH7KH¿QDO¿OWHULQJVWHS
OHIWDWRWDORIJHQHV)RUWKH$II\PHWUL[([RQ
ST arrays, we used the Affymetrix Power Tools (APT) 
to generate gene-level (core meta-probeset) expression 
YDOXHVIURPUDZ&(/¿OHV$UUD\VZHUHQRUPDOL]HGXVLQJ
50$ ZKLFK LQFOXGHG 50$ EDFNJURXQG FRUUHFWLRQ
quantile normalization, log transformation, and probeset 
VXPPDUL]DWLRQ 'HWHFWLRQ DERYH EDFNJURXQG '$%*
was performed at both the probe and the probeset 
OHYHO XVLQJ *&PDWFKHG EDFNJURXQG SUREHV DQG ORZ
YDULDQFHSUREHVHWVZHUHH[FOXGHGJHQHV)RUWKH
Heidelberg data set, the pre-processed data was directly 
obtained from the GEO database. Probes with more than 
PLVVLQJYDOXHVZHUH¿OWHUHGRXWDQGWKHSUREHVHWZLWK
the highest average expression value was retained when 
removing duplicate probesets for a gene (18,913 genes).
Differential expression analysis
Two different approaches were applied to the 
normalized data to identify differentially expressed genes 
EHWZHHQLQWUDFUDQLDODQGVSLQDOHSHQG\PRPDV7KH¿UVW
approach uses a meta-analysis that combines effect sizes 
from each dataset into a pooled effect size to estimate the 
amount of change in expression across all datasets. In each 
data set, the effect size was calculated for each gene using 
+HGJHV¶DGMXVWHGJ$UDQGRPHIIHFWVPRGHOZDVXVHGWR
combine effect sizes to obtain the pooled effect size and 
LWVVWDQGDUGHUURU>@7KH]VWDWLVWLFZDVFRPSXWHGDVD
ratio of the pooled effect size to its standard error for each 
gene, and the result was compared to a standard normal 
distribution to obtain a nominal p-value. P- values were 
FRUUHFWHGIRUPXOWLSOHK\SRWKHVHVWHVWLQJXVLQJ%HQMDPLQL
Hochberg correction. The second approach uses a 
non-parametric meta-analysis that combines p-values 
from individual studies. A moderated t-statistic based 
on empirical Bayesian method was calculated for each 
gene in each study [37]. Fishers sum of logs was used 
to combine the p-values obtained from each study and 
ZHUHFRUUHFWHGIRUPXOWLSOHK\SRWKHVHVXVLQJ%HQMDPLQL
Hochberg correction. The corrected P value, False 
Discovery Rate (FDR) less than 5% was used to select 
the differentially expressed genes between intracranial and 
spinal ependymomas.
NF2 gene correlation analysis
The correlation between NF2 gene expression and 
other genes was calculated using the Pearson correlation 
method for each data set separately. DerSimonian-Laird 




z-scores. P values obtained from the meta-analysis were 
FRUUHFWHGZLWK%HQMDPLQL+RFKEHUJPHWKRG:HXVHGWKH
=PHDQRIFRUUHODWLRQFRHI¿FLHQWV!DQG)'5
WR VHOHFW VLJQL¿FDQWO\ FRUUHODWHG JHQHV ZLWK 1) JHQH
expression.
*HQHVHWHQULFKPHQWDQGSDWKZD\DQDO\VLV
The over-representation analyses for Gene Ontology 
(GO) terms, Kyoto Encyclopedia of Genes and Genomes 
(KEGG), and Panther pathways, were carried out with 
GeneCodis [39]. The REVIGO software was used to 
VXPPDUL]H DQG YLVXDOL]H VLJQL¿FDQW *2 WHUPV >@
The overlap between differentially expressed genes 
and chromosomal positions (C1: positional gene sets 




of statistically enriched functional categories, pathways, 
and gene sets was estimated with hypergeometric test and 
the p-values were corrected for the multiple comparisons 
by estimating the FDR. 
3ULRULWL]DWLRQRIGRZQUHJXODWHGJHQHVORFDWHGLQ
chromosome 22
1HWZRUN DQDO\VLV RI SURWHLQSURWHLQ LQWHUDFWLRQV
33,ZDVXVHGWRSULRULWL]HVLJQL¿FDQWO\GRZQUHJXODWHG
genes in SEPN that are located in chromosome 22. The 
33,QHWZRUNVLQFOXGLQJGLUHFWDQGLQGLUHFWDPRQJWKHVH
genes were extracted from InWeb, a well-characterized 
PPI database developed by Lage et al [42]. To evaluate 




'$33/( ZDV XVHG WR DVVHVV WKH VLJQL¿FDQFH RI 33,
QHWZRUNZLWKSHUPXWDWLRQV>@
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